Cetera Investment Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.3M | Buy |
106,790
+9,776
| +10% | +$3.63M | 0.04% | 465 |
|
|
2026
Q1 | $28.4M | Buy |
97,014
+16,058
| +20% | +$5.28M | 0.03% | 556 |
|
|
2025
Q4 | $28.4M | Buy |
80,956
+2,751
| +4% | +$930K | 0.03% | 517 |
|
|
2025
Q3 | $25.3M | Buy |
78,205
+14,771
| +23% | +$4.59M | 0.03% | 544 |
|
|
2025
Q2 | $24.7M | Buy |
63,434
+3,438
| +6% | +$1.38M | 0.04% | 444 |
|
|
2025
Q1 | $26.1M | Buy |
59,996
+9,855
| +20% | +$3.96M | 0.05% | 380 |
|
|
2024
Q4 | $18.5M | Sell |
50,141
-4,053
| -7% | -$1.7M | 0.04% | 458 |
|
|
2024
Q3 | $28.2M | Buy |
54,194
+3,110
| +6% | +$1.66M | 0.06% | 315 |
|
|
2024
Q2 | $27.7M | Sell |
51,084
-8,904
| -15% | -$4.71M | 0.06% | 306 |
|
|
2024
Q1 | $31.1M | Buy |
59,988
+49,883
| +494% | +$24.8M | 0.07% | 271 |
|
|
2023
Q4 | $4.76M | Sell |
10,105
-2,455
| -20% | -$1.14M | 0.04% | 451 |
|
|
2023
Q3 | $5.47M | Buy |
12,560
+1,073
| +9% | +$487K | 0.05% | 387 |
|
|
2023
Q2 | $5.1M | Buy |
11,487
+527
| +5% | +$243K | 0.04% | 406 |
|
|
2023
Q1 | $5.04M | Buy |
10,960
+1,800
| +20% | +$857K | 0.04% | 394 |
|
|
2022
Q4 | $4.7M | Sell |
9,160
-222
| -2% | -$113K | 0.04% | 404 |
|
|
2022
Q3 | $4K | Buy |
9,382
+2,316
| +33% | +$1.11M | ﹤0.01% | 1679 |
|
|
2022
Q2 | $3.41M | Buy |
7,066
+277
| +4% | +$137K | 0.05% | 347 |
|
|
2022
Q1 | $3.33M | Sell |
6,789
-352
| -5% | -$161K | 0.05% | 391 |
|
|
2021
Q4 | $3.31M | Buy |
7,141
+879
| +14% | +$370K | 0.05% | 396 |
|
|
2021
Q3 | $2.33M | Buy |
6,262
+261
| +4% | +$99.2K | 0.04% | 469 |
|
|
2021
Q2 | $2.29M | Buy |
6,001
+304
| +5% | +$116K | 0.04% | 467 |
|
|
2021
Q1 | $2.04M | Sell |
5,697
-423
| -7% | -$136K | 0.04% | 416 |
|
|
2020
Q4 | $1.97M | Buy |
6,120
+4,830
| +374% | +$1.48M | 0.04% | 434 |
|
|
2020
Q3 | $346K | Sell |
1,290
-30
| -2% | -$8.07K | 0.03% | 466 |
|
|
2020
Q2 | $347K | Buy |
+1,320
| New | +$352K | 0.03% | 439 |
|
|
2020
Q1 | – | Sell |
-841
| Closed | -$255K | – | 570 |
|
|
2019
Q4 | $255K | Buy |
+841
| New | +$231K | 0.03% | 484 |
|
|
2019
Q3 | – | Sell |
-788
| Closed | -$223K | – | 546 |
|
|
2019
Q2 | $223K | Sell |
788
-210
| -21% | -$57.4K | 0.03% | 462 |
|
|
2019
Q1 | $287K | Sell |
998
-149
| -13% | -$43.1K | 0.04% | 380 |
|
|
2018
Q4 | $299K | Buy |
1,147
+392
| +52% | +$108K | 0.05% | 337 |
|
|
2018
Q3 | $207K | Buy |
+755
| New | +$196K | 0.03% | 454 |
|
|
2016
Q4 | – | Sell |
-2,457
| Closed | -$308K | – | 331 |
|
|
2016
Q3 | $308K | Buy |
+2,457
| New | +$317K | 0.13% | 188 |
|
Other funds holding ELV
Cetera Investment Advisers's ELV Position: Q2 2026 in Review
Cetera Investment Advisers increased its Elevance Health (ELV) stake by 10% in Q2 2026, buying an estimated $3.63M and bringing the position to 106,790 shares worth $41.3M. The position accounts for 0.04% of the portfolio, ranked #465.
Cetera Investment Advisers first reported a position in ELV in Q3 2016 and has held it in 31 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Cetera Investment Advisers held 106,790 shares of Elevance Health worth $41.3M as of Q2 2026.
- Cetera Investment Advisers bought 9,776 Elevance Health shares in Q2 2026, an estimated $3.63M.
- Elevance Health made up 0.04% of Cetera Investment Advisers's portfolio in Q2 2026, its #465 holding.
- Cetera Investment Advisers first reported a position in Elevance Health in Q3 2016 and has held it in 31 quarters since.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.